MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,197,400 | -21.5% | 319,740 | -2.5% | 0.00% | – |
| Q2 2023 | $4,075,088 | -92.5% | 327,843 | -91.6% | 0.00% | -100.0% |
| Q1 2023 | $54,505,000 | +97287.7% | 3,890,477 | -0.5% | 0.01% | 0.0% |
| Q4 2022 | $55,967 | -99.9% | 3,911,032 | +9.1% | 0.01% | -46.2% |
| Q3 2022 | $91,520,000 | -8.8% | 3,584,772 | +1.5% | 0.01% | -7.1% |
| Q2 2022 | $100,303,000 | -16.2% | 3,530,561 | +4.0% | 0.01% | 0.0% |
| Q1 2022 | $119,728,000 | -18.6% | 3,394,600 | -3.3% | 0.01% | -17.6% |
| Q4 2021 | $147,120,000 | -24.4% | 3,511,207 | -11.5% | 0.02% | -29.2% |
| Q3 2021 | $194,679,000 | -4.4% | 3,966,555 | -18.8% | 0.02% | 0.0% |
| Q2 2021 | $203,724,000 | +30.4% | 4,881,951 | +11.4% | 0.02% | +14.3% |
| Q1 2021 | $156,232,000 | +34.5% | 4,383,637 | +5.9% | 0.02% | +23.5% |
| Q4 2020 | $116,155,000 | – | 4,140,989 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |